Evidence map›Paper›PMID 22179018›Full record

ArticleArchives of biochemistry and biophysics2012

Mitochondrial calpain 10 is degraded by Lon protease after oxidant injury.

Matthew A Smith, Rick G Schnellmann

Open access · greenAbstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Matthew A SmithCenter for Cell Death, Injury, and Regeneration, Department of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, Charleston, SC 29425, United States.
Rick G Schnellmann
Medical University of South Carolina · USRalph H. Johnson VA Medical Center · US

Funding

Mitochondrial Biogenesis Promotes Recovery From Oxidant InjuryR01GM084147 · NIGMS · UNIVERSITY OF ARIZONA · PI SCHNELLMANN, RICK G · 2008 to 2016
$2.4M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2002 to 2002
$2.0M
MITOCHONDRIAL CALPAIN MEDIATED RENAL CELL DEATHR01ES012239 · NIEHS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SCHNELLMANN, RICK G · 2004 to 2007
$1.1M
Training Program in Environmental Stress SignalingT32ES012878 · NIEHS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SCHNELLMANN, RICK G · 2005 to 2010
$681k
NCRR NIH HHS C06 RR-015455NCRR NIH HHS C06 RR015455NIEHS NIH HHS R01 ES012239NIEHS NIH HHS T32 ES012878NIGMS NIH HHS GM 084147NIGMS NIH HHS R01 GM084147
6 · The paper itself

Abstract

Calpain 10 is ubiquitously expressed and is one of four mitochondrial matrix proteases. We determined that over-expression or knock-down of mitochondrial calpain 10 results in cell death, demonstrating that mitochondrial calpain 10 is required for viability. Thus, we studied calpain 10 degradation in isolated mitochondrial matrix, mitochondria and in renal proximal tubular cells (RPTC) under control and toxic conditions. Using isolated renal cortical mitochondria and mitochondrial matrix, calpain 10 underwent rapid degradation at 37°C that was blocked with Lon inhibitors but not by calpain or proteasome inhibitors. While exogenous Ca(2+) addition, Ca(2+) chelation or exogenous ATP addition had no effect on calpain 10 degradation, the oxidants tert-butyl hydroperoxide (TBHP) or H(2)O(2) increased the rate of degradation. Using RPTC, mitochondrial and cytosolic calpain 10 increased in the presence of MG132 (Lon/proteasome inhibitor) but only cytosolic calpain 10 increased in the presence of epoxomicin (proteasome inhibitor). Furthermore, TBHP and H(2)O(2) oxidized mitochondrial calpain 10, decreased mitochondrial, but not cytosolic calpain 10, and pretreatment with MG132 blocked TBHP-induced degradation of calpain 10. In summary, mitochondrial calpain 10 is selectively degraded by Lon protease under basal conditions and is enhanced under and oxidizing conditions, while cytosolic calpain 10 is degraded by the proteasome.

Indexed as

Adenosine TriphosphateAnimalsCalpainCarbonyl Cyanide p-TrifluoromethoxyphenylhydrazoneCisplatinFemaleIn Vitro TechniquesKidney CortexKidney Tubules, ProximalKineticsMitochondriaOxidantsProtease InhibitorsProtease LaRabbitsRNA, MessengerAdenosine TriphosphateCalpaincalpain 10Carbonyl Cyanide p-TrifluoromethoxyphenylhydrazoneCisplatinOxidantsProtease InhibitorsProtease LaRNA, Messenger

Identifiers

PMID22179018
PMCPMC3258974
OpenAlexW2103984906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.